Although no authorization for commercialization of genetically
modified (GM) fish products for human consumption
exists at present (beginning 2008) in North America and
Europe, several genetically modified fish or shellfish (aquatic
genetically modified organisms (GMOs)) are in development or
have been said to be close to market for some years already
(FAO, 2003). Among them, transgenic salmon is at the head of
the list, and thus a review of this product may be useful to
elucidate the numerous issues which should be considered
within the authorization assessment process, including social,
economic, public health and environmental concerns